Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib improved ulcerative colitis, skin ulcers, and hair loss in a patient who didn't respond well to other treatments.

A patient developed nerve problems as a side effect of a hair loss treatment called tofacitinib.

Oral tofacitinib shows promise in treating atopic dermatitis and alopecia areata, but only slight improvement in vitiligo.

The protein FLCN is involved in cellular cleanup and is regulated by ULK1.

Targeting immune pathways like JAK/STAT may help treat frontal fibrosing alopecia.

Frontal Fibrosing Alopecia is a poorly understood condition that is hard to treat and causes distressing hair loss.

Combination therapy with steroids and pimecrolimus improved or stabilized hair loss in most patients with Frontal Fibrosing Alopecia, who also had a high rate of hypothyroidism.

Dutasteride may help stabilize Frontal Fibrosing Alopecia, but more research is needed.

A compound made by Pfizer can potentially stimulate hair growth and reduce oil production, making it a good candidate for topical use.

New vitamin D3 forms need the vitamin D receptor to reduce fibrosis in human cells.

Tofacitinib effectively treated a woman's complex autoimmune and autoinflammatory disorders.

Tofacitinib is effective and safe for elderly patients with ulcerative colitis.

Hormonal imbalances may play a role in frontal fibrosing alopecia, and antiandrogenic drugs combined with steroids are currently the most effective treatment.

Baricitinib shows promise in improving frontal fibrosing alopecia symptoms.

Afatinib often causes skin problems that need proactive management.

The new drug delivery system effectively targets lung cancer cells.

Finasteride significantly reduced tics and obsessive-compulsive symptoms in Tourette syndrome patients.

The article concludes that understanding Frontal Fibrosing Alopecia (FFA) is crucial for effective treatment, which includes medication like 5α-reductase inhibitors and hydroxychloroquine.

Agalsidase alfa helps treat Fabry's disease but needs more research for long-term benefits.

A new carrier improves skin delivery of tofacitinib for treating inflammatory skin diseases.

Folliculin helps regulate energy and nutrient sensing, impacting Birt–Hogg–Dubé syndrome.

The cause of Frontal Fibrosing Alopecia is unclear, diagnosis involves clinical evaluation and various treatments exist, but their effectiveness is uncertain.

Fetuin A may increase collagen production and promote scarring.

Isotretinoin can effectively reduce symptoms of frontal fibrosing alopecia.

Activating the Nrf2 pathway reduces inflammation and cell activation in human hair follicles, suggesting a potential treatment for certain hair loss conditions.

Tofacitinib helped regrow hair in most adolescents with alopecia areata, but more research is needed.

Effective treatment guidelines for frontal fibrosing alopecia are still unclear.

S5αR inhibitors might help treat schizophrenia and other mental disorders but need more research.

Tofacitinib shows promise for treating severe hair loss in adults and teens, with many experiencing regrowth, but hair loss returns when treatment stops.